Kura Oncology (KURA) Misses Q2 EPS by 34c

Kura Oncology (NASDAQ: KURA) reported Q2 EPS of ($0.75), $0.34 worse than the analyst estimate of ($0.41). Revenue for the quarter came in at $15.3 million versus the consensus estimate of $39.11 million.

For earnings history and earnings-related data on Kura Oncology (KURA) click here.

You May Also Be Interested In

• Pizza Hut CEO Aaron Powell resigns
• NVIDIA (NVDA) Said To Near $14 bln Deal For Hugging Face This Week - Bloomberg
• GitLab Inc (GTLB) Tops Q2 EPS by 7c, Beats on Revenue